Thyroid sequelae of COVID-19: a systematic review of reviews.
COVID-19
Coronavirus
Thyroid
Thyroiditis
Journal
Reviews in endocrine & metabolic disorders
ISSN: 1573-2606
Titre abrégé: Rev Endocr Metab Disord
Pays: Germany
ID NLM: 100940588
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
accepted:
05
04
2021
pubmed:
13
4
2021
medline:
12
5
2021
entrez:
12
4
2021
Statut:
ppublish
Résumé
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has the potential to cause multi-organ effects including endocrine disorders. The impact of COVID-19 on the thyroid gland has been described but several aspects have to be clarified. The systematic review was conceived to achieve more solid information about: 1) which thyroid disease or dysfunction should be expected in COVID-19 patients; 2) whether thyroid patients have a higher risk of SARS-CoV-2 infection; 3) whether the management has to be adapted in thyroid patient when infected. The literature was searched by two authors independently. A 5-step search strategy was a priori adopted. Only reviews focused on the relationship between thyroid and COVID-19 were included. The last search was performed on February 21
Identifiants
pubmed: 33843008
doi: 10.1007/s11154-021-09653-1
pii: 10.1007/s11154-021-09653-1
pmc: PMC8038866
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
485-491Références
WHO Director-General’s opening remarks at the media briefing on COVID-19. News release. March 11, 2020. Accessed 12 Mar 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 (last update February 21th, 2021)
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395:497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
doi: 10.1016/S0140-6736(20)30183-5
pubmed: 31986264
Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. https://doi.org/10.1136/bmj.m1091
doi: 10.1136/bmj.m1091
pubmed: 32217556
pmcid: 32217556
Marazuela M, Giustina A, Puig-Domingo M. Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord. 2020;1–13. https://doi.org/10.1007/s11154-020-09569-2
Fernandez Martinez A, Barajas Galindo D, Ruiz SJ. Management of hyponatraemia and hypernatraemia during the Covid-19 pandemic: a consensus statement of the Spanish Society for Endocrinology (Acqua Neuroendocrinology Group). Rev Endocr Metab Disord. 2021;5:1–8. https://doi.org/10.1007/s11154-021-09627-3
doi: 10.1007/s11154-021-09627-3
Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2020;25:1–13. https://doi.org/10.1007/s11154-020-09615-z
doi: 10.1007/s11154-020-09615-z
Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu ST, Villani L, Magri F, Latrofa F, Chiovato L. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2020;6:1–6. https://doi.org/10.1007/s40618-020-01436-w
doi: 10.1007/s40618-020-01436-w
Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45. https://doi.org/10.1186/s40249-020-00662-x
doi: 10.1186/s40249-020-00662-x
pubmed: 32345362
pmcid: 7186534
Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132–40. https://doi.org/10.1097/XEB.0000000000000055
doi: 10.1097/XEB.0000000000000055
pubmed: 26360830
Dworakowska D, Grossman AB. Thyroid disease in the time of COVID-19. Endocrine. 2020;68(3):471–4. https://doi.org/10.1007/s12020-020-02364-8
doi: 10.1007/s12020-020-02364-8
pubmed: 32507963
pmcid: 7275975
Gorini F, Bianchi F, Iervasi G. COVID-19 and Thyroid: Progress and Prospects. Int J Environ Res Public Health. 2020;17(18):6630. https://doi.org/10.3390/ijerph17186630
doi: 10.3390/ijerph17186630
pmcid: 7559547
Caron P. Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management. Ann Endocrinol (Paris). 2020;81(5):507–10. https://doi.org/10.1016/j.ando.2020.09.001
doi: 10.1016/j.ando.2020.09.001
Kumari K, Chainy GBN, Subudhi U. Prospective role of thyroid disorders in monitoring COVID-19 pandemic. Heliyon. 2020;6(12):e05712. https://doi.org/10.1016/j.heliyon.2020.e05712
doi: 10.1016/j.heliyon.2020.e05712
pubmed: 33344794
pmcid: 7733548
Chen W, Tian Y, Li Z, Zhu J, Wei T, Lei J. Potential interaction between SARS-CoV-2 and thyroid: A review. Endocrinology. 2021 Mar 1;162(3):bqab004. https://doi.org/10.1210/endocr/bqab004
Speer G, Somogyi P. Thyroid complications of SARS and coronavirus disease 2019 (COVID-19). Endocr J. 2021;68(2):129–36. https://doi.org/10.1507/endocrj.EJ20-0443
doi: 10.1507/endocrj.EJ20-0443
pubmed: 33473054
Croce L, Gangemi D, Ancona G, Liboà F, Bendotti G, Minelli L, Chiovato L. The cytokine storm and thyroid hormone changes in COVID-19. J Endocrinol Invest. 2021;9:1–14. https://doi.org/10.1007/s40618-021-01506-7
doi: 10.1007/s40618-021-01506-7
Piticchio T, Le Moli R, Tumino D, Frasca F. Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic-A comprehensive review. J Endocrinol Invest. 2021;13:1–18. https://doi.org/10.1007/s40618-020-01486-0
doi: 10.1007/s40618-020-01486-0
Kerslake R, Hall M, Randeva HS, et al. Co-expression of peripheral olfactory receptors with SARS-CoV-2 infection mediators: Potential implications beyond loss of smell as a COVID-19 symptom. Int J Mol Med. 2020;46(3):949–956. https://doi.org/10.3892/ijmm.2020.4646
Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020;383(2):120–128. https://doi.org/10.1056/NEJMoa2015432
Dufort EM, Koumans EH, Chow EJ, et al. Multisystem Inflammatory Syndrome in Children in New York State. N Engl J Med 2020;383(4):347–358. https://doi.org/10.1056/NEJMoa2021756
Coperchini F, Chiovato L, Ricci G, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved. Cytokine Growth Factor Rev. 2021;S1359–6101(20):30242–52. https://doi.org/10.1016/j.cytogfr.2020
doi: 10.1016/j.cytogfr.2020
Java A, Apicelli AJ, Liszewski MK, et al. The complement system in COVID-19: friend and foe?. JCI Insight. 2020;5(15):140711. https://doi.org/10.1172/jci.insight.140711
Guo Y, Korteweg C, McNutt MA, Gu J. Pathogenetic mechanisms of severe acute respiratory syndrome. Virus Res. 2008;133(1):4–12. https://doi.org/10.1016/j.virusres.2007.01.022
doi: 10.1016/j.virusres.2007.01.022
pubmed: 17825937
Rotondi M, Nieto-Diaz M, Magri F, Oliviero A. Balancing the need for rapid and rigorous scientific data during early phase of the COVID-19 pandemic: A further role for the scientific community. Eur J Intern Med. 2020;77:152. https://doi.org/10.1016/j.ejim.2020.05.037
doi: 10.1016/j.ejim.2020.05.037
pubmed: 32487369
pmcid: 7253989
Mebis L, Debaveye Y, Visser TJ, Van den Berghe G. Changes within the thyroid axis during the course of critical illness. Endocrinol Metab Clin North Am. 2006;35(4):807–21.
doi: 10.1016/j.ecl.2006.09.009
Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015;3(10):816–25.
doi: 10.1016/S2213-8587(15)00225-9
Franceschi C, Ostan R, Mariotti S, Monti D, Vitale G. The Aging Thyroid: A Reappraisal Within the Geroscience Integrated Perspective. Endocr Rev. 2019;40(5):1250–70. https://doi.org/10.1210/er.2018-00170
doi: 10.1210/er.2018-00170
pubmed: 31074798
Ruggeri RM, CampennÌ A, Giuffrida G, Casciaro M, Barbalace MC, Hrelia S, Trimarchi F, CannavÒ S, Gangemi S. Oxidative stress as a key feature of autoimmune thyroiditis: an update. Minerva Endocrinol. 2020;45(4):326–44. https://doi.org/10.23736/S0391-1977.20.03268-X
doi: 10.23736/S0391-1977.20.03268-X
pubmed: 32969631
pmcid: 32969631
Cippà PE, Cugnata F, Ferrari P, Brombin C, Ruinelli L, Bianchi G, Beria N, Schulz L, Bernasconi E, Merlani P, Ceschi A, Di Serio C. A data-driven approach to identify risk profiles and protective drugs in COVID-19. Proc Natl Acad Sci U S A. 2021;118(1):e2016877118. https://doi.org/10.1073/pnas.2016877118.Erratum.In:ProcNatlAcadSciUSA.2021Feb23;118(8):PMID:33303654;PMCID:PMC7817222
doi: 10.1073/pnas.2016877118.Erratum.In:ProcNatlAcadSciUSA.2021Feb23;118(8):PMID:33303654;PMCID:PMC7817222
pubmed: 33303654
Mendel CM, Frost PH, Kunitake ST, Cavalieri RR. Mechanism of the heparin-induced increase in the concentration of free thyroxine in plasma. J Clin Endocrinol Metab. 1987;65(6):1259–64.
doi: 10.1210/jcem-65-6-1259
SARS-CoV-2 and Hypo-/Hyperthyroidism - eurothyroid.com. February 20th, 2021
van Gerwen M, Alsen M, Little C, Barlow J, Naymagon L, Tremblay D, Sinclair CF, Genden E. Outcomes of patients with hypothyroidism and COVID-19: A retrospective cohort study. Front Endocrinol (Lausanne). 2020;18(11):565. https://doi.org/10.3389/fendo.2020.00565
doi: 10.3389/fendo.2020.00565
Brix TH, Hegedüs L, Hallas J, Lund LC. Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism. Lancet Diabetes Endocrinol. 2021;S2213–8587(21):00028. https://doi.org/10.1016/S2213-8587(21)00028-0
doi: 10.1016/S2213-8587(21)00028-0